Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
191 participants
INTERVENTIONAL
2018-07-06
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Use of High-Flow Nasal Cannula Oxygen Therapy in Intensive Care Units Patients
NCT04141956
Pilot Physiological Evaluation of an Investigational Mask with Expiratory Washout.
NCT06007495
Effect of a Personalized Weaning Strategy on Weaning Success
NCT05719194
Respiratory Variability and Dyspnea During Spontaneous Breathing Trial
NCT05762614
Conduct of Nasal High Flow Oxygen in Acute Respiratory Failure
NCT03311087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no treatment, open label
Multiple breath nitrogen washout
Lung Clearance Index (LCI) will be performed in healthy volunteers with a multiple breath nitrogen washout device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple breath nitrogen washout
Lung Clearance Index (LCI) will be performed in healthy volunteers with a multiple breath nitrogen washout device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy subjects with a social insurance
Exclusion Criteria
* Premature birth (\<37th weeks of amenorrhea)
* Acute lower respiratory viral infection within 3 weeks before Multiple Breath washout
3 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Femme Mère Enfant
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Philippe REIX, Pr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL18_0064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.